http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#Head
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#assertion
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#provenance
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#pubinfo
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#assertion
http://purl.obolibrary.org/obo/DOID_2983
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_2983
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00887
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association
http://www.w3.org/2000/01/rdf-schema#label
Bumetanide is contraindicated in anuria. Although bumetanide tablets can be used to induce diuresis in renal insufficiency, any marked increase in blood urea nitrogen or creatinine, or the development of oliguria during therapy of patients with progressive renal disease, is an indication for discontinuation of treatment with bumetanide tablets. Bumetanide is also contraindicated in patients in hepatic coma or in states of severe electrolyte depletion until the condition is improved or corrected. Bumetanide is contraindicated in patients hypersensitive to this drug.
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00887
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#provenance
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#pubinfo
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig
http://purl.org/nanopub/x/hasSignature
IZumphNKrv/d3Q91ts1dpJjhYaWw2BgaTtDe8r2ccVnhLNLrPY4YffcLBY6B8hg5Y1kC31Porq57Lo2N4qce4KxSXorHiPfZpsjhocLmraM1Rq/t4FvRqm8sTr2q6/LeJN0ldjDqFaYChZAPe+d7aR0a9MjGojbSz9iQ2YjC5ao=
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
http://purl.org/dc/terms/created
2021-08-23T19:12:45.253+02:00
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY